Steven Vail Fine Arts: A superstar, a design star and a populist star

Presswire, 6 May 2021

Steven Vail Fine Arts in Des Moines' recent acquisitions of Julian Schnabel works has seen interest from collectors in Berlin, Miami, Greece, Beverly Hills and others. The gallery has also featured a different contemporary female artist each week in March on their virtual tour to honor Women’s Heritage Month. They are transitioning in May to an international theme...

Vinturas - Appointment of new Chief Executive Officer

Presswire, 6 May 2021

Vinturas, digital operating platform and initiative of 6 European leading logistics experts in the automotive industry, appoints new CEO...

European Campaign gives Kidneys a stage! ERA-EDTA launches the European Kidney Health Awareness Days

Presswire, 5 May 2021

One in ten adults in Europe suffer from reduced kidney function and yet many will be unaware of this. What is fatal is that the loss of kidney function cannot be reversed. It is therefore essential that the general public are made aware of the importance of the kidneys and how to protect them.

Cómo pueden los responsables políticos fomentar la cooperación energética en parques industriales – Informes de políticas de S-PARCS sobre las barreras más obstructivas y la mejor manera de superarlas

Presswire, 4 May 2021

Se han publicado nuevos informes dirigidos a los responsables políticos, en el marco del proyecto S-PARCS H2020, para ayudar a la creación de marcos legales y reglamentarios que aceleren/faciliten la cooperación energética en los polígonos industriales, maximizando el ahorro de energía y garantizando la competitividad de empresas ubicadas en estos parques.

“Industrial Park Service Initial Assessment Tool” (IAT), una nueva herramienta para evaluar el potencial energético de los parques industriales

Presswire, 4 May 2021

La nueva herramienta "Industrial Park Service Initial Assessment Tool" (IAT) está destinada a maximizar el ahorro energético y garantizar la competitividad de las empresas ubicadas en los parques industriales.

Energiekooperationen in Industrieparks fördern: S-PARCS’ Policy Briefs zu Barrieren für Energiekooperation und wie man sie am besten meistern kann

Presswire, 4 May 2021

Im Rahmen des H2020-Projekts S-PARCS wurden Policy Briefs veröffentlicht, die Möglichkeiten beschreiben, wie Änderungen an bestehenden rechtlichen und regulatorischen Rahmenbedingungen dabei helfen können, Energiekooperationen in Industrieparks zu beschleunigen und zu erleichtern.

“Industrial Park Service Initial Assessment Tool” (IAT), ein neues Tool zur Bewertung des Energiepotenzials von Industrieparks

Presswire, 4 May 2021

Das "Industrial Park Service Initial Assessment Tool" (IAT) ist ein neues Online-Werkzeug, das Industriepark-Manager und Unternehmen bei der Durchführung einer ersten Einschätzung möglicher ungenutzter Energiekooperationspotenziale in Industrieparks unterstützt. Das IAT ist online auf der E-Plattform der S-PARCS-Community verfügbar, zu finden unter diesem Link: https://www.sparcs-community.eu/.

How policymakers can foster energy cooperation in industrial parks: S-PARCS briefs on overcoming barriers

Presswire, 4 May 2021

New policy briefs have been published in the framework of the H2020 S-PARCS project, to assist in the creation of legal and regulatory frameworks that accelerate and facilitate energy cooperation in industrial parks, thus maximizing energy savings and guaranteeing the competitiveness of companies located in these parks.

Industrial Park Service Initial Assessment Tool (IAT) to assess industrial parks’ energy potential

Presswire, 4 May 2021

The “Industrial Park Service Initial Assessment Tool” (IAT) is a new tool destined to maximize energy savings and guarantee the competitiveness of companies located in industrial parks.

CEBINA reports potency of azelastine against emerging dominant variants of SARS-CoV-2 in laboratory testing

Presswire, 4 May 2021

CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.

Pages

Subscribe to Greatreporter RSS